Merck

3 Microcap Biopharma Plays For The H7N9 Influenza Outbreak
Seeking Alpha
Wed, 04/17/13 - 11:07 am
Flu
H7N9
Sanofi
Novavax
Biocryst
Gilead
GSK
Merck
Roche
Inovio
Achillion: Moving Beyond Sofosbuvir's Shadow
Seeking Alpha
Tue, 04/16/13 - 11:55 am
sofosbuvir
Achillion
AbbVie
Bristol-Myers Squibb
Gilead
Merck
Idenix
Merck's Latest Drug and Strategy Concoctions
Motley Fool
Tue, 04/16/13 - 10:22 am
Merck
Pfizer
Eli Lilly
patents
Discovery Laboratories Stumbles
Seeking Alpha
Tue, 04/16/13 - 10:20 am
Discovery Labs
Abbott Laboratories
Merck
JNJ
Pfizer
Surfaxin
3 Undeniably Awesome Health Care Dividend Stocks
Motley Fool
Sat, 04/13/13 - 12:10 pm
GSK
Merck
Medical Properties Trust
FDA reviewing pill form of Merck drug to block fungal infections in immune-compromised people
Yahoo/AP
Thu, 04/11/13 - 11:29 am
FDA
Merck
antifungals
Noxafil
Will the FDA Wake Up to This Drug's Potential?
Motley Fool
Tue, 04/9/13 - 10:42 am
FDA
Merck
sugammadex
anesthesia reversal agent
Can Merck Field a Psoriasis Blockbuster?
Motley Fool
Tue, 04/9/13 - 09:44 am
Merck
psoriasis
MK-3222
Merck & Co: Growth Will Become Stagnant
Seeking Alpha
Mon, 04/8/13 - 10:59 am
Merck
This Week in Biotech
Motley Fool
Sun, 04/7/13 - 10:55 am
JNJ
Optimer
Biogen
Merck
Cubist Pharmaceuticals
AstraZeneca
Rigel Pharmaceuticals
AbbVie
Pfizer
India's top court rebuffs Merck, lets generic Januvia roll out
Fierce Pharma
Fri, 04/5/13 - 11:42 am
India
Merck
Januvia
diabetes
generics
Glenmark
A Critical Analysis Of Pfizer's Pipeline, Earnings And Valuation
Seeking Alpha
Fri, 04/5/13 - 10:23 am
Pfizer
JNJ
GSK
Abbott Laboratories
Merck
Novartis
3 Ways Big Pharma Is Seizing This Rare Opportunity
Motley Fool
Fri, 04/5/13 - 10:21 am
Merck
Endocyte
Eli Lilly
Pfizer
Repligen
AbbVie
Protalix BioTherapeutics
Experimental sleep drug may cause fewer side effects -Merck study
Reuters
Thu, 04/4/13 - 09:16 am
Merck
suvorexant
insomnia
Lunesta
Ambien
Merck’s Fosamax on Trial Again After First Case Halted
Bloomberg
Thu, 04/4/13 - 09:14 am
Merck
Fosamax
osteoporosis
A Clouded Future For Big Pharma's Blockbuster Diabetes Drugs
Seeking Alpha
Wed, 04/3/13 - 10:48 am
diabetes
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Novo Nordisk
Merck
Incretin
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tue, 04/2/13 - 10:58 am
Arena Pharmaceuticals
Zogenix
Delcath
Aveo Pharmaceutical
Vivus
Titan Pharmaceuticals
Bristol-Myers Squibb
Merck
Gilead
AbbVie
Amarin
Achillion
Sangamo BioSciences
Raptor Pharmaceuticals
Vertex Pharmaceuticals
NewLink Genetics
AstraZeneca
Rigel
Depomed
Biogen Idec
Sucampo
Dendreon
Valeant Pharmaceuticals
GSK
Aegerion
Johnson & Johnson's New Diabetes Drug And Its Competitors
Seeking Alpha
Tue, 04/2/13 - 09:52 am
JNJ
diabetes
Invokana
Merck
Januvia
Byetta
Bristol-Myers Squibb
Four Factors Driving Amgen's Stock Price To $102
Seeking Alpha
Mon, 04/1/13 - 10:38 am
Amgen
AbbVie
Bristol-Myers Squibb
JNJ
Merck
Eli Lilly
Pfizer
Eli Lilly's Livalo: A Big Win For Patients And Investors
Seeking Alpha
Fri, 03/29/13 - 10:52 am
Eli Lilly
Livalo
HIV
Kowa
GSK
Merck
Pfizer
AstraZeneca

Pages